top of page

Leadership

DISRUPT brings together multidisciplinary teams from four New York City institutions, Mount Sinai’s Tisch Cancer Institute (TCI), Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), Montefiore Einstein Cancer Center (MECC) and The City College of New York (CCNY).

 

These cancer centers are charged with reducing cancer disparities that affect approximately two million people residing in some of the most diverse and underserved communities in the United States.

mountsinai-og-logo.jpg
Columbia2-e1554892052465.png
einstein-logo-hi-res.png
CCNYlogo_FlushRight_digital.jpg
bickell - innovator wall pic.JPG

Dr. Nina Bickell

MD, MPH

Project Leader

Nina Bickell, MD, MPH, has spent the past 20 years focusing on underlying reasons for disparities in the quality of cancer care many BIPOC patients get and designing different approaches to improve their cancer care. Dr. Bickell is a member of the senior leadership team at The Tisch Cancer Institute (TCI).

11583-bruce-rapkin.jpg

Bruce D. Rapkin

Ph.D

Team Principal

My research focuses on building community-academic partnerships that can reduce barriers and improve standard of care.

parisa headshot_edited.jpg

Dr. Parisa Tehranifar

DrPH

 Co-investigator

Parisa Tehranifar, DrPH is a cancer epidemiologist and health disparities researcher. Her research focuses on improving the implementation of breast cancer screening and prevention in racially and ethnically diverse, immigrant and underserved communities. 

lounsbury_headshot_edited.jpg

Dr. David Lounsbury

PhD

 Co-investigator

​David Lounsbury is an Associate Professor of Epidemiology and Population Health and Associate Director of Patient-Centered Outcomes Research Training at the Albert Einstein College of Medicine. As a community psychologist and a systems scientist, David designs and conducts research that strives to strengthen community partnerships to improve the way health care works in the Bronx and beyond.  

hubbard_1.jpg

Dr. Karen Hubbard

Ph.D

Project Co-Leader

Dr. Hubbard is a molecular biologist who studies gene expression during cellular aging.  Her research focuses on RNA metabolism during aging and the relationship between cell death (apoptosis) and aging.

Herzberg headshot.jpg

Dr. Ben Herzberg

MD

Team Principal

My research interests are in lung cancer and cancers with special difficulties repairing damage to their DNA. I develop clinical trials using novel agents targeting DNA repair, bringing these drugs directly to my patients in the clinic. 

mt146_3_marybeth.jpg

Mary Beth Terry

Ph.D

Co-investigator

Mary Beth Terry, PhD, focuses her research on environmental modifiers of cancer risk. She is the Director of Community Outreach and Engagement with the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. She has spent over 20 years leading studies of cancer risk reduction in local communities and around the world.  

dr hillyer.PNG

Dr. Grace Hillyer

EdD

Co-investigator

Dr. Hillyer’s expertise lies in the applied use of behavioral theory to investigate multilevel
psychological, social, and cultural factors impacting health behavior among underrepresented
and underserved populations and the application of mixed research methodology to construct
and implement tailored educational interventions.

Community Advocates:

index.jpg

Dr. Zorina Costello

D. Min., M.Div., MS

Director of Community Engagement, Center for Spirituality and Health Mount Sinai Health System

Desireģe Walker Bio Pic 2021(1).jpg

Desiree A.H. Walker

Health Education and Patient Advocate

Desirée serves as an advocate for patients by openly speaking about her diagnoses to audiences nationally and internationally

newivisphoto-02.jpg

Ivis Sampayo

SHARE Cancer Support

Chief Diversity Officer and Senior Director of Public Outreach

Additional Clinical Sites:

3-1-1-about-west.jpg

Mount Sinai West

26BETHISRAEL-superJumbo.jpg

Mount Sinai Beth Israel

bottom of page